![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg\")
<\/figure>\n\n\n\nTheory and practice of intellectual property
\u2116 3 \/ 2019<\/p>\n\n\n\n
ISSN (Print) 2308-0361
ISSN (Online) 2519-2744<\/p>\n\n\n\n
![\"\"](\"https:\/\/test.inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png\"){kind=icon}
PDF (Ukrainian)<\/a><\/div>\n<\/div>\n\n\n\nDOI: https:\/\/doi.org\/10.33731\/32019.173811<\/a><\/p>\n\n\n\n Published \u00a0\u00a0\u00a0\u00a0\u00a02019-07-19<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n<\/div>\n\n\n\n Compulsory and voluntary drug licenses: some aspects of enforcement<\/strong><\/p>\n\n\n\n Olena Ponomarova<\/strong> Abstract Keywords: <\/strong>compulsory license, voluntary license, medicine, property rights<\/p>\n\n\n\n References<\/strong><\/p>\n\n\n\n \u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0442\u043e\u0440\u0433\u0456\u0432\u0435\u043b\u044c\u043d\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442e\u0430\u0443\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0432 \u0440\u0435\u0434\u0430\u043a\u0446\u0456\u0457 \u0432\u0456\u0434 06.12.2005 \u0440\u043e\u043a\u0443. \u041f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u043f\u0440\u0430\u0432 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0438 \u0442\u0430 \u043a\u043e\u0440\u0438\u0441\u043d\u0456 \u043c\u043e\u0434\u0435\u043b\u0456 : \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 15.12.1993 \u0440\u043e\u043a\u0443 \u2116 3769-\u0425\u0406\u0406 (\u0437\u0456 \u0437\u043c\u0456\u043d\u0430\u043c\u0438). Theory and practice of intellectual property\u2116 3 \/ 2019 ISSN (Print) 2308-0361ISSN (Online) 2519-2744 DOI: https:\/\/doi.org\/10.33731\/32019.173811 Published \u00a0\u00a0\u00a0\u00a0\u00a02019-07-19 Compulsory and voluntary drug licenses: some aspects of enforcement Olena PonomarovaUkraine AbstractThe purpose of the article is to study the peculiarities of the legal nature of non-contractual forms of realization of intellectual property rights in the field […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10601","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/10601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/comments?post=10601"}],"version-history":[{"count":2,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/10601\/revisions"}],"predecessor-version":[{"id":10603,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/10601\/revisions\/10603"}],"wp:attachment":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/media?parent=10601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2025\/11\/CC-2.png\")
<\/figure>\n\n\n\n
Ukraine<\/p>\n\n\n\n
<\/strong>The purpose of the article is to study the peculiarities of the legal nature of non-contractual forms of realization of intellectual property rights in the field of medicine, to which we in the process of research include: compulsory, open and voluntary licenses. These forms of realization of intellectual property rights in the field of medicine received their legal regulation outside the scope of contractual law. Today, thanks to the adoption of the Doha Declaration, science-intensive pharmaceutical companies, operating within the framework of corporate social responsibility, increasingly use open licenses, allowing generic manufacturers to produce and sell generic versions of their products within a given geographic region. Today, most companies that own intellectual property rights for HIV \/ AIDS treatment drugs use open licensing or immunity from prosecution with generic manufacturers or sign an agreement to refuse to prosecute for violation of their patent rights to drugs for the treatment of HIV \/ AIDS. Such an agreement is called – an open, voluntary license agreement unlike a compulsory license. In the article, we propose changes to the legislation of Ukraine, which will lead to harmonization of national patent law with the European Patent Convention and best European practices of law enforcement, and consequently, as a result, will allow establishing a fair balance between the interests of patent winners and the rights of citizens of Ukraine to access medicines.<\/p>\n\n\n\n
http:\/\/zakon2.rada.gov.ua\/laws\/show\/981_018<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/3687-12<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"